1*1 Environment Canada Environnement Canada p. 1 _MXA 55e!

of Katherine E.

3Afl A&2S16- $S7Z 3M ENVIRONMENTAL LABORATORY PROJECT NO.E05-0442 Analytical Report Definitive Study: Quantitative Screening of Commercial Lots of Human Serum Obtained in 2004 for Endogenous Fluorochemicals Using Solid Phase Extraction and Liquid Chromatography/Tandem Mass Spectrometry Laboratory Request Num ber EQ5-0442 Testing Laboratory 3M Environmental Health and Safety Operations 3M Environmental Laboratory' _________________ _ _ _____________________________________________ ;_________ _ 3M Environmental Laboratory Project Lead Mark E.

RECEIVED irrt cno OfrJUL-5 AHII: 22 AK 2Z _ 373Z Self-Reported Medical Conditions in Perfluorooctanesulfonyl Fluoride Manufacturing Workers Final Report Bruce H.

WVU :: Printer Friendly: WVU :: School of Medicine :: Community Medicine :: C8 Page 1 o f 1 Printed from: http://www.hsc.wvu.edu/som/cmed/c8/results/C8AndPFCLevels/index.asp Page Printed: April 7, 2008 WVU :: School of Medicine :: Community Medicine :: C8 C8 Health Project Results C8 & Other PFC Levels The tables and graphs on this page (links below) are summary results for the plasma concentrations of C8 and C8 Sulfonate of the participants in the C8 Health Project.

ANALYTICAL REPORT STL STL Denver 4955 Yarrow Street Arvada, CO 80002 Tel: 303 736 0100 Fax: 303 431 7171 www.stl-inc.com PFOATFOS Analysis Lot#: D7D180342 Laura Vancho/Jane Hanszczyk NJ American Water 213 Carriage Lane Delran, NJ 08075 Severn Trent Laboratories, Inc .

P-1 Taft Stettinius & Hollister LLP 425 Walnut Street, Suite 1 8 0 0 /Cincinnati, OH 4 5 2 0 2 -3 9 5 7 /Tel: 5 1 3 ,3 8 1 .2 8 3 8 /Fax: 5 1 3 .3 8 1 .0 2 0 5 / www.taftlaw.com Cincinnati / Cleveland / Columbus / Dayton / Indianapolis / Northern Kentucky / Phoenix / Beijing Robert A.

I 3M Corporate Toxicology and Regulatory Services 3M Center, Building 0220-02-E-02 St.

BACK TO MAIN 3M FLUOROCHEMICAL SUBMISSION TOXICOLOGY, EPIDEMIOLOGY AND MEDICAL SURVEILLANCE April 2004 Click on Study Title to View Report April 16, 2004 Butenhoff, J.L., et al., "Characterization of Risk for General Population Exposure to Perfluorooctanoate," Regulatory Toxicology and Pharmacology 39 (2004) 363-380, April 16, 2004

BACK TO MAIN 3M FLUOROCHEMICAL SUBMISSION TOXICOLOGY, EPIDEMIOLOGY AND MEDICAL SURVEILLANCE ATTACHMENT TO LETTER OF 1/18/05 Click on Study Title to View Report Multiple Chemicals Page: 1 1.

At*S-/ff Toxicological Summary PFOS Dietary Chronic Pilot Reproductive Study: Mallard Test Substance: Perfluorooctanesulfonate (PFOS) Structure: 1-Octanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoropotassium salt, CAS# 2795-39-3 Test Remarks: The test substance is a white powder (3M Lot #217).

Toxicological Summary PFOS Dietary Acute Northern Bobwhite Study Test Substance: Perfluorooctanesulfonate (PFOS) Structure: 1-Octanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-, potassium salt, CAS# 2795-39-3 Remarks: The test substance is a white powder (3M lot #217).

A m & -1105 Sponsor: 3M St.

AR226-2006 INTEROFFICE MEMORANDUM Date: From; Dept; Tel No; 14-Mar-1383 10:34om William A.

AR226-2224 g ?